» Articles » PMID: 34686734

Dementia Subtype Prediction Models Constructed by Penalized Regression Methods for Multiclass Classification Using Serum MicroRNA Expression Data

Overview
Journal Sci Rep
Specialty Science
Date 2021 Oct 23
PMID 34686734
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

There are many subtypes of dementia, and identification of diagnostic biomarkers that are minimally-invasive, low-cost, and efficient is desired. Circulating microRNAs (miRNAs) have recently gained attention as easily accessible and non-invasive biomarkers. We conducted a comprehensive miRNA expression analysis of serum samples from 1348 Japanese dementia patients, composed of four subtypes-Alzheimer's disease (AD), vascular dementia, dementia with Lewy bodies (DLB), and normal pressure hydrocephalus-and 246 control subjects. We used this data to construct dementia subtype prediction models based on penalized regression models with the multiclass classification. We constructed a final prediction model using 46 miRNAs, which classified dementia patients from an independent validation set into four subtypes of dementia. Network analysis of miRNA target genes revealed important hub genes, SRC and CHD3, associated with the AD pathogenesis. Moreover, MCU and CASP3, which are known to be associated with DLB pathogenesis, were identified from our DLB-specific target genes. Our study demonstrates the potential of blood-based biomarkers for use in dementia-subtype prediction models. We believe that further investigation using larger sample sizes will contribute to the accurate classification of subtypes of dementia.

Citing Articles

Machine learning uncovers novel sex-specific dementia biomarkers linked to autism and eye diseases.

Khan A, Ghasemi A, Ingram K, Ay A J Alzheimers Dis Rep. 2025; 9:25424823251317177.

PMID: 40034518 PMC: 11864256. DOI: 10.1177/25424823251317177.


Integrated network pharmacology and molecular docking to investigate the potential mechanism of Tufuling on Alzheimer's disease.

Zhang Z, Cheng J, Zhou X, Wu H, Zhang B Heliyon. 2024; 10(16):e36471.

PMID: 39253234 PMC: 11382023. DOI: 10.1016/j.heliyon.2024.e36471.


Identification of prognostic RNA editing profiles for clear cell renal carcinoma.

Chen W, Li S, Huang D, Su Y, Wang J, Liang Z Front Med (Lausanne). 2024; 11:1390803.

PMID: 39091293 PMC: 11291244. DOI: 10.3389/fmed.2024.1390803.


Exploring the Regulatory Landscape of Dementia: Insights from Non-Coding RNAs.

Kim J, Kim W, Park E, Lee D, Lee Y, Shin H Int J Mol Sci. 2024; 25(11).

PMID: 38892378 PMC: 11172830. DOI: 10.3390/ijms25116190.


Alcohol Use Disorder and Dementia: A Review.

Zahr N Alcohol Res. 2024; 44(1):03.

PMID: 38812709 PMC: 11135165. DOI: 10.35946/arcr.v44.1.03.


References
1.
Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View

2.
Ragusa M, Bosco P, Tamburello L, Barbagallo C, Condorelli A, Tornitore M . miRNAs Plasma Profiles in Vascular Dementia: Biomolecular Data and Biomedical Implications. Front Cell Neurosci. 2016; 10:51. PMC: 4771726. DOI: 10.3389/fncel.2016.00051. View

3.
Kirouac L, Rajic A, Cribbs D, Padmanabhan J . Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease. eNeuro. 2017; 4(2). PMC: 5367084. DOI: 10.1523/ENEURO.0149-16.2017. View

4.
Kayano M, Higaki S, Satoh J, Matsumoto K, Matsubara E, Takikawa O . Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis. Biomark Res. 2016; 4():22. PMC: 5151129. DOI: 10.1186/s40364-016-0076-1. View

5.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View